Completed PHASE1 INTERVENTIONAL 2-arm NCT02783638

PK and Food Effect of Pregabalin Study After Dosing in Healthy Male Volunteers

A Open-label, Randomized, Crossover Clinical Trial to Assess the PK of Pregabalin CR After Multiple Dosing as Compared to Pregabalin IR and the Food Effect of High Fat Diet After Single Dosing in Healthy Male Volunteers

Sponsor: Yuhan Corporation

Conditions Peripheral Neuropathy Pain

Interventions Lyrica YHD1119

Updated 7 times since 2017 Last updated: Jan 14, 2019 Started: Jan 31, 2016 Primary completion: Apr 30, 2016 Completion: Sep 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Peripheral Neuropathy Pain, this trial is completed. The trial is conducted by Yuhan Corporation and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE1
Sep 2024 — Sep 2025 [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Feb 2019 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Yuhan Corporation

Data source: Yuhan Corporation

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jeonju, South Korea